Leukemia & Lymphoma, Volume 51, Issue 12 (2010)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 51, Issue 12 (2010)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Volume 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentary on selected articles in this issue

Article Commentary
Getting to the root of the stem cell in mutated chronic myeloid leukemia
Sarah M. Larson & Lucy A. Godley
Pages: 2147-2148
Published online: 06 Dec 2010
CitationforGetting to the root of the stem cell in mutated chronic myeloid leukemia | Full Text | References | PDF (131.5 KB)
  • 604 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
High dose melphalan in primary systemic amyloidosis: status quo?
Efstathios Kastritis & Meletios A. Dimopoulos
Pages: 2149-2151
Published online: 06 Dec 2010
First Page PreviewforHigh dose melphalan in primary systemic amyloidosis: status quo? | Full Text | References | PDF (136.3 KB)
  • 420 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Waldenström macroglobulinemia: is newer really better?
Morie A. Gertz
Pages: 2152-2153
Published online: 11 Nov 2010
CitationforWaldenström macroglobulinemia: is newer really better? | Full Text | References | PDF (134.5 KB)
  • 392 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring
Avichai Shimoni & Arnon Nagler
Pages: 2154-2156
Published online: 06 Dec 2010
First Page PreviewforIncreasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring | Full Text | References | PDF (138 KB)
  • 518 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Correlation between IDH2 mutations and disease status in acute myeloid leukemia
Elizabeth A. Eklund, Pradip Raychaudhuri & Leonidas C. Platanias
Pages: 2157-2158
Published online: 07 Oct 2010
CitationforCorrelation between IDH2 mutations and disease status in acute myeloid leukemia | Full Text | References | PDF (133.6 KB)
  • 561 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma
Sham Mailankody, Esther Mena, Constance M. Yuan, Arun Balakumaran, W. Michael Kuehl & Ola Landgren
Pages: 2159-2170
Published online: 20 Oct 2010
AbstractforMolecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma | Full Text | References | PDF (1.2 MB)
  • 585 Views
  • 18 CrossRef citations
  • 0Altmetric
Review Article
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010
Michel Meignan, Andrea Gallamini, Corinne Haioun & Aaron Polliack
Pages: 2171-2180
Published online: 15 Nov 2010
AbstractforReport on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010 | Full Text | References | PDF (197.8 KB)
  • 867 Views
  • 110 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, Shaji K. Kumar, David Dingli, Stephen M. Ansell, Dennis A. Gastineau, David J. Inwards, Patrick B. Johnston, Mark R. Litzow, Ivana N. M. Micallef, Luis F. Porrata, Nelson Leung, William J. Hogan & Francis K. Buadi
Pages: 2181-2187
Published online: 20 Oct 2010
AbstractforAutologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report | Full Text | References | PDF (323.2 KB)
  • 524 Views
  • 85 CrossRef citations
  • 0Altmetric
Article
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia
Stefan Peinert, Constantine S. Tam, H. Miles Prince, John Scarlett, Max M. Wolf, E. Henry Januszewicz, David Westerman & John F. Seymour
Pages: 2188-2197
Published online: 12 Oct 2010
AbstractforFludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia | Full Text | References | PDF (330.4 KB)
  • 170 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988–2005: an analysis of 21 734 cases
Faiha Bazzeh, Rawad Rihani, Scott Howard & Iyad Sultan
Pages: 2198-2207
Published online: 05 Nov 2010
AbstractforComparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988–2005: an analysis of 21 734 cases | Full Text | References | PDF (695.6 KB)
  • 537 Views
  • 55 CrossRef citations
  • 0Altmetric
Article
Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience
Han-Nan Lin, Chun-Yu Liu, Ying-Chung Hong, Jih-Tung Pai, Ching-Fen Yang, Yuan-Bin Yu, Liang-Tsai Hsiao, Tzeon-Jye Chiou, Jin-Hwang Liu, Jyh-Pyng Gau, Cheng-Hwai Tzeng & Po-Min Chen
Pages: 2208-2214
Published online: 05 Nov 2010
AbstractforClinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience | Full Text | References | PDF (319.3 KB)
  • 164 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma
Gustavo J. Lourenço, Irene Lorand-Metze, Marcia T. Delamain, Eliana C. M. Miranda, Rodolfo Kameo, Konradin Metze & Carmen S. P. Lima
Pages: 2215-2221
Published online: 26 Oct 2010
AbstractforPolymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma | Full Text | References | PDF (289.5 KB)
  • 132 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia
Tait Shanafelt, Clive Zent, John Byrd, Charles Erlichman, Betsy Laplant, Asish Ghosh, Timothy Call, Miguel Villalona-Calero, Diane Jelinek, Deborah Bowen, Kristina Laumann, Wenting Wu, Curtis Hanson & Neil Kay
Pages: 2222-2229
Published online: 05 Nov 2010
AbstractforPhase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia | Full Text | References | PDF (693.3 KB)
  • 218 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior
Junichi Tomomatsu, Yasushi Isobe, Kazuo Oshimi, Yoko Tabe, Kiyoshi Ishii, Masaaki Noguchi, Takao Hirano, Norio Komatsu & Koichi Sugimoto
Pages: 2230-2239
Published online: 11 Nov 2010
AbstractforChronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior | Full Text | References | PDF (751.7 KB)
  • 286 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease
Peter H. O'Donnell, Andrew S. Artz, Samir D. Undevia, Rish K. Pai, Paula Del Cerro, Sarah Horowitz, Lucy A. Godley, John Hart, Federico Innocenti, Richard A. Larson, Olatoyosi M. Odenike, Wendy Stock & Koen Van Besien
Pages: 2240-2249
Published online: 04 Oct 2010
AbstractforPhase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease | Full Text | References | PDF (308.2 KB)
  • 341 Views
  • 26 CrossRef citations
  • 0Altmetric
Article
Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience
Marcelo Iastrebner, Jun Ho Jang, Elsa Nucifora, Kihyun Kim, Federico Sackmann, Dong Hwan Kim, Sergio Orlando, Chul Won Jung, Ana Basquiera, Graciela Klein, Fernando Santini, Haydee I. Bernard, Jorge Korin & Gustavo Taborda
Pages: 2250-2257
Published online: 07 Oct 2010
AbstractforDecitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience | Full Text | References | PDF (425.7 KB)
  • 440 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine
Seah H. Lim, John Mcmahan, Jian Zhang & Yana Zhang
Pages: 2258-2261
Published online: 11 Nov 2010
AbstractforA phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine | Full Text | References | PDF (148.6 KB)
  • 260 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China
Xiao-Jun Xu, Yong-Min Tang, Hua Song, Shi-Long Yang, Shu-Wen Shi & Jian Wei
Pages: 2262-2269
Published online: 07 Oct 2010
AbstractforLong-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China | Full Text | References | PDF (466.2 KB)
  • 234 Views
  • 24 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Study of specific genetic and epigenetic variables in multiple myeloma
Eleftheria Hatzimichael, Aggeliki Dasoula, Leonidas Benetatos, Nelofer Syed, George Dranitsaris, Tim Crook & Konstantinos Bourantas
Pages: 2270-2274
Published online: 11 Nov 2010
AbstractforStudy of specific genetic and epigenetic variables in multiple myeloma | Full Text | References | PDF (176.5 KB)
  • 184 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Analysis of genome-wide methylation and gene expression induced by 5-aza-2′-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia
Emiliano Fabiani, Giuseppe Leone, Manuela Giachelia, Francesco D'alo'Mariangela Greco, Marianna Criscuolo, Francesco Guidi, Sergio Rutella, Stefan Hohaus & Maria Teresa voso
Pages: 2275-2284
Published online: 15 Nov 2010
AbstractforAnalysis of genome-wide methylation and gene expression induced by 5-aza-2′-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia | Full Text | References | PDF (920.7 KB) | Supplemental
  • 797 Views
  • 37 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status
Ivana Jeziskova, Filip Razga, Monika Bajerova, Zdenek Racil, Jiri Mayer & Dana Dvorakova
Pages: 2285-2287
Published online: 07 Oct 2010
First Page PreviewforIDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status | Full Text | References | PDF (219.9 KB)
  • 148 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination
Sylvain Pilorge, Sophie Park, François Dreyfus, Didier Bouscary & Jerome Tamburini
Pages: 2288-2290
Published online: 07 Oct 2010
First Page PreviewforRituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination | Full Text | References | PDF (135.6 KB)
  • 116 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Complete remission following treatment with bortezomib, doxorubicin, dexamethasone and autologous stem cell transplant in patient with immunoglobulin E multiple myeloma
Ryszard Pogłód, Maria Kraj, Barbara Kruk, Renata Hagedorna-Tronina, Magdalena Łętowska & Krzysztof Warzocha
Pages: 2291-2294
Published online: 07 Oct 2010
First Page PreviewforComplete remission following treatment with bortezomib, doxorubicin, dexamethasone and autologous stem cell transplant in patient with immunoglobulin E multiple myeloma | Full Text | References | PDF (277.1 KB)
  • 60 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Statin use and need for therapy in chronic lymphocytic leukemia
Daphne R. Friedman, Lindsay A. Magura, Holly A. C. Warren, Jeremy D. Harrison, Louis F. Diehl & J. Brice Weinberg
Pages: 2295-2298
Published online: 07 Oct 2010
First Page PreviewforStatin use and need for therapy in chronic lymphocytic leukemia | Full Text | References | PDF (216.1 KB)
  • 224 Views
  • 15 CrossRef citations
  • 0Altmetric
Letter
Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy
Rebecca Howman, Arti Thakerer, Matthew Pitman, Nik Ding, Philip A. Thompson, Amit Khot & Simon J. Harrison
Pages: 2299-2302
Published online: 07 Oct 2010
First Page PreviewforBortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy | Full Text | References | PDF (260.4 KB)
  • 335 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
A case of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-unrelated but Epstein–Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection
Anna R. Cooper, W. Richard Burack & Jeffrey P. Allerton
Pages: 2303-2305
Published online: 07 Oct 2010
First Page PreviewforA case of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-unrelated but Epstein–Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection | Full Text | References | PDF (215.7 KB)
  • 97 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Proteomic profile of a therapy related acute myeloid leukemia following brain tumor
Maria Braoudaki, George T. Tsangaris, Kalliopi Karamolegou, Athanasios K. Anagnostopoulos, Neophytos Prodromou & Fotini Tzortzatou-Stathopoulou
Pages: 2306-2309
Published online: 07 Oct 2010
First Page PreviewforProteomic profile of a therapy related acute myeloid leukemia following brain tumor | Full Text | References | PDF (404.2 KB)
  • 77 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Numb chin syndrome as the initial manifestation of acute megakaryoblastic leukemia
Konstantinos Liapis, Ioannis Apostolidis, Themistokles Karmiris & Nikolaos Harhalakis
Pages: 2310-2311
Published online: 07 Oct 2010
CitationforNumb chin syndrome as the initial manifestation of acute megakaryoblastic leukemia | Full Text | References | PDF (174.4 KB)
  • 59 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles